<DOC>
	<DOCNO>NCT02627261</DOCNO>
	<brief_summary>Three method include flow cytometry , next generation sequence determination circulate tumor cell perform different time point patient previously undiagnosed multiple myeloma order determine sensitive method detect residual disease</brief_summary>
	<brief_title>Multiple Myeloma Minimal Residual Disease</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>â‰¥ 18 year previously undiagnosed myeloma eligible high dose therapy bone marrow transplantation sign consent ongoing therapy another neoplasia Patients hematologic malignancy , patient deprive liberty administrative judicial reason previously treat myeloma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>residual disease</keyword>
</DOC>